Tff Pharmaceuticals Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Tff Pharmaceuticals current Real Value cannot be determined due to lack of data. The regular price of Tff Pharmaceuticals is $0.0. Our model measures the value of Tff Pharmaceuticals from inspecting the company fundamentals such as Return On Equity of -2.14, shares owned by insiders of 3.31 %, and Current Valuation of (2.27 M) as well as reviewing its technical indicators and probability of bankruptcy.
Tff Pharmaceuticals Total Value Analysis
Tff Pharmaceuticals is at this time forecasted to have valuation of (2.27 M) with market capitalization of 288.8 K, debt of 115.25 K, and cash on hands of 13.15 M. The negative valuation of Tff Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Tff Pharmaceuticals fundamentals.Takeover Price | Market Cap | Debt Obligations | Cash |
(2.27 M) | 288.8 K | 115.25 K | 13.15 M |
Tff Pharmaceuticals Investor Information
About 24.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.09. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tff Pharmaceuticals recorded a loss per share of 5.5. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 19th of December 2023. Based on the key indicators related to Tff Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Tff Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Tff Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Tff Pharmaceuticals has an asset utilization ratio of 6.1 percent. This connotes that the Company is making $0.061 for each dollar of assets. An increasing asset utilization means that Tff Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Tff Pharmaceuticals Ownership Allocation
Tff Pharmaceuticals has 3.31 % of its outstanding shares held by insiders and 24.37 % owned by institutional holders.Tff Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 733.87 K. Net Loss for the year was (21.24 M) with loss before overhead, payroll, taxes, and interest of (21.21 M).Tff Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Tff Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding | 1.8 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Tff Stock
If you are still planning to invest in Tff Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tff Pharmaceuticals' history and understand the potential risks before investing.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Transaction History View history of all your transactions and understand their impact on performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data |